These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3497323)

  • 1. Fluoxetine subsensitizes a nicotinic mechanism involved in the regulation of core temperature.
    Dilsaver SC; Davidson RK
    Life Sci; 1987 Aug; 41(9):1165-9. PubMed ID: 3497323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desipramine subsensitizes nicotinic mechanism involved in regulating core temperature.
    Dilsauer SC; Hariharen M; Davidson RK
    Psychiatry Res; 1988 Jul; 25(1):105-8. PubMed ID: 3265210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic injections of saline produce subsensitivity to nicotine.
    Flemmer DD; Dilsaver SC
    Pharmacol Biochem Behav; 1989 Oct; 34(2):261-3. PubMed ID: 2622980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bright artificial light produces subsensitivity to nicotine.
    Dilsaver SC; Majchrzak MJ
    Life Sci; 1988; 42(2):225-30. PubMed ID: 3336277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constant exposure to darkness produces supersensitivity to nicotine.
    Flemmer DD; Dilsaver SC
    Pharmacol Biochem Behav; 1990 Mar; 35(3):523-6. PubMed ID: 2339143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone.
    Dwivedi Y; Rizavi HS; Pandey GN
    Neuroscience; 2006; 139(3):1017-29. PubMed ID: 16500030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants and protein kinases: inhibition of Ca2+-regulated myosin phosphorylation by fluoxetine and iprindole.
    Silver PJ; Sigg EB; Moyer JA
    Eur J Pharmacol; 1986 Feb; 121(1):65-71. PubMed ID: 2869958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine and fluoxetine induce arousing effects on sleep-wake cycle in antidepressive doses: a possible mechanism of antidepressant-like effects of nicotine.
    Vázquez-Palacios G; Hernández-González M; Guevara Pérez MA; Bonilla-Jaime H
    Pharmacol Biochem Behav; 2010 Feb; 94(4):503-9. PubMed ID: 19931302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine.
    Wong DT; Bymaster FP
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):41-51. PubMed ID: 6974884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiologic effects of bright artificial light.
    Dilsaver SC
    Brain Res Brain Res Rev; 1989; 14(4):311-33. PubMed ID: 2624898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsensitivity of the norepinephrine receptor-coupled adenylate cyclase system in brain: effects of nisoxetine versus fluoxetine.
    Mishra R; Janowsky A; Sulser F
    Eur J Pharmacol; 1979 Dec; 60(4):379-82. PubMed ID: 316774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenelzine produces subsensitivity to nicotine.
    Dilsaver SC; Hariharan M; Davidson RK
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Sep; 17(5):847-60. PubMed ID: 8255990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of specific inhibitors of 5-hydroxytryptamine uptake on thermoregulation in rats.
    Lin MT
    J Physiol; 1978 Nov; 284():147-54. PubMed ID: 310457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of brain serotonin alterations on hypothermia produced by chlorpromazine in rats.
    Lin MT; Chern YF; Chow CF; Li YP
    Pharmacology; 1979; 18(3):128-35. PubMed ID: 156373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with amitriptyline produces supersensitivity to nicotine.
    Dilsaver SC; Majchrzak MJ; Alessi NE
    Biol Psychiatry; 1988 Jan; 23(2):169-75. PubMed ID: 3334885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial light and nicotine subsensitivity.
    Dilsaver SC
    Biol Psychiatry; 1988 Aug; 24(4):437-40. PubMed ID: 3408759
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.
    Cryan JF; Page ME; Lucki I
    Psychopharmacology (Berl); 2005 Nov; 182(3):335-44. PubMed ID: 16001105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications.
    Brady LS; Gold PW; Herkenham M; Lynn AB; Whitfield HJ
    Brain Res; 1992 Feb; 572(1-2):117-25. PubMed ID: 1351783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacologic profile of fluoxetine.
    Stark P; Fuller RW; Wong DT
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses.
    Saletu B; Grünberger J
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):45-52. PubMed ID: 3882681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.